Evidence map›Paper›PMID 35837043›Full record

ArticleExperimental and therapeutic medicine2022

Differential expression profiles of miRNA in granulomatous lobular mastitis and identification of possible biomarkers.

Jie Ling, Xianmin Xie, Yue Wang, Weifang Huang, Jun Luo, Jingqun Su, Hongqiao Fan, Shiting Wu, Lifang Liu

Open access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jie LingGraduate School, Hunan University of Chinese Medicine, Changsha, Hunan 41000, P.R. China.
Xianmin XieDepartment of Hand Surgery, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan 41000, P.R. China.
Yue WangDepartment of Galactophore, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan 41000, P.R. China.
Weifang HuangGraduate School, Hunan University of Chinese Medicine, Changsha, Hunan 41000, P.R. China.
Jun LuoGraduate School, Hunan University of Chinese Medicine, Changsha, Hunan 41000, P.R. China.
Jingqun SuGraduate School, Hunan University of Chinese Medicine, Changsha, Hunan 41000, P.R. China.
Hongqiao FanDepartment of Galactophore, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan 41000, P.R. China.
Shiting WuDepartment of Galactophore, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan 41000, P.R. China.
Lifang LiuDepartment of Galactophore, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan 41000, P.R. China.
First Affiliated Hospital of Hunan University of Traditional Chinese Medicine · CNHunan University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The etiology and pathogenesis of granulomatous lobular mastitis (GLM) remain largely elusive and the expression levels and regulatory roles of microRNAs (miRNAs or miRs) in GLM have remained mostly undetermined. In the present study, the miRNAs that were differentially expressed in breast biopsy samples from patients with GLM and normal tissue adjacent to fibroadenoma were analyzed, a comprehensive differential expression profile of miRNAs was provided and potential biomarkers were screened out. The expression profile of miRNAs was determined by high-throughput sequencing in the tissues of patients with GLM and healthy controls. Significantly differentially expressed miRNAs were screened by threshold setting and cluster analysis and their target genes were analyzed by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment. Finally, circulating differentially expressed miRNAs between the GLM and control groups were further analyzed by reverse transcription-quantitative PCR (RT-qPCR). A total of 31,077 miRNAs were detected by high-throughput sequencing. By using the cutoff criteria of |log2 fold change|>2.5 and q<0.001, 13 miRNAs that were indicated to be GLM biomarkers were screened out. The expression levels of these 13 miRNAs in the GLM group were higher than those in the control group. GO and KEGG enrichment analyses suggested that the occurrence and development of GLM may be associated with autoimmune inflammation, metabolism and pathogenic organisms. miR-451a and miR-5571-3p were confirmed to be significantly increased in the serum of patients with GLM compared with their levels in the serum of healthy volunteers, which suggests that they may be used as biomarkers of GLM. To the best of our knowledge, the present study was the first report detailing genome-wide miRNA profiling of patients with GLM compared with controls. The possible targets and pathways of GLM were evaluated by bioinformatics analysis. The present study identified 13 differentially expressed miRNAs with important theoretical significance and potential application. Furthermore, miR-451a and miR-5571-3p were verified by RT-qPCR as possible biomarkers of GLM.

Indexed as

biomarkergene expression profilesgranulomatous lobular mastitishigh-throughput sequencingmiRNA

Identifiers

PMID35837043
PMCPMC9257833
OpenAlexW4281640310

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.